NCT01708720View on ClinicalTrials.gov

Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

February 29, 2012

Conditions
Poliomyelitis
Interventions
DRUG

IPV

DRUG

Sabin-IPV

DRUG

Adjuvanted Sabin-IPV

Trial Locations (1)

Unknown

Szpital Internistyczny cetrum Badan Farmakologii Klinicznej Monipol Sp. z o.o., Krakow

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

Pauline Verdijk

OTHER_GOV

NCT01708720 - Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults | Biotech Hunter | Biotech Hunter